Taysha Gene Therapies Q3'26 Revenue Estimate Is 755.56K USD
Q3'26 results are expected November 10; revenue is estimated at 755.56 thousand USD and EPS at (0.13) USD. The release time is not specified.
TSHA (Taysha Gene Therapies, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 755.56 thousand USD with EPS (earnings per share) anticipated at (0.13) USD. Learn more d…